Literature DB >> 23147843

Multiple sclerosis: oral BG12 for treatment of relapsing-remitting MS.

Volker Limmroth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23147843     DOI： 10.1038/nrneurol.2012.231

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  6 in total

1.  [Treatment of psoriasis vulgaris].

Authors:  W SCHWECKENDIEK
Journal:  Med Monatsschr       Date:  1959-02

2.  Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.

Authors:  S Schimrigk; N Brune; K Hellwig; C Lukas; B Bellenberg; M Rieks; V Hoffmann; D Pöhlau; H Przuntek
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

3.  Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Authors:  Robert J Fox; David H Miller; J Theodore Phillips; Michael Hutchinson; Eva Havrdova; Mariko Kita; Minhua Yang; Kartik Raghupathi; Mark Novas; Marianne T Sweetser; Vissia Viglietta; Katherine T Dawson
Journal:  N Engl J Med       Date:  2012-09-20       Impact factor: 91.245

4.  Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.

Authors:  Ralf Gold; Ludwig Kappos; Douglas L Arnold; Amit Bar-Or; Gavin Giovannoni; Krzysztof Selmaj; Carlo Tornatore; Marianne T Sweetser; Minhua Yang; Sarah I Sheikh; Katherine T Dawson
Journal:  N Engl J Med       Date:  2012-09-20       Impact factor: 91.245

5.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

6.  Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

Authors:  Ludwig Kappos; Ralf Gold; David H Miller; David G Macmanus; Eva Havrdova; Volker Limmroth; Chris H Polman; Klaus Schmierer; Tarek A Yousry; Minhua Yang; Mefkûre Eraksoy; Eva Meluzinova; Ivan Rektor; Katherine T Dawson; Alfred W Sandrock; Gilmore N O'Neill
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321
  6 in total
  9 in total

1.  Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2.

Authors:  Zhe Ji; Zhiqin Fan; Ying Zhang; Ronghuan Yu; Haihua Yang; Chenghua Zhou; Jia Luo; Zun-Ji Ke
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

2.  Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.

Authors:  Brigid K Jensen; Hubert Monnerie; Maggie V Mannell; Patrick J Gannon; Cagla Akay Espinoza; Michelle A Erickson; Annadora J Bruce-Keller; Benjamin B Gelman; Lisa A Briand; R Christopher Pierce; Kelly L Jordan-Sciutto; Judith B Grinspan
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

3.  Dimethyl fumarate ameliorates endotoxin-induced acute kidney injury against macrophage oxidative stress.

Authors:  Kejun Zhou; Mengyi Xie; Shuli Yi; Yun Tang; Haojun Luo; Qiong Xiao; Jun Xiao; Yi Li
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

4.  Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.

Authors:  Alessandra Lugaresi; Maria di Ioia; Daniela Travaglini; Erika Pietrolongo; Eugenio Pucci; Marco Onofrj
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-24       Impact factor: 2.570

5.  The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.

Authors:  Paweł Kawalec; Alicja Mikrut; Natalia Wiśniewska; Andrzej Pilc
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

6.  CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis.

Authors:  Fozia Mir; Donald Lee; Hetal Ray; Saud A Sadiq
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-08-14

7.  Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.

Authors:  Victoria A McGuire; Tamara Ruiz-Zorrilla Diez; Christoph H Emmerich; Sam Strickson; Maria Stella Ritorto; Ruhcha V Sutavani; Anne Weiβ; Kirsty F Houslay; Axel Knebel; Paul J Meakin; Iain R Phair; Michael L J Ashford; Matthias Trost; J Simon C Arthur
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

8.  Role of oral teriflunomide in the management of multiple sclerosis.

Authors:  Radu Tanasescu; Nikos Evangelou; Cris S Constantinescu
Journal:  Neuropsychiatr Dis Treat       Date:  2013-04-22       Impact factor: 2.570

9.  Obesity Promotes EAE Through IL-6 and CCL-2-Mediated T Cells Infiltration.

Authors:  Zhe Ji; Shuai Wu; Yaru Xu; Jingjing Qi; Xiaohui Su; Lei Shen
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.